Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

24 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Recruiting

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

NCT06940830

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Zagreb, Croatia
  • Sobi Investigational Site Brno, Czechia
  • Sobi Investigational Site Ostrava, Czechia
  • Sobi Investigational Site Prague, Czechia
View all 29 locations
View Trial Details
Recruiting

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +16 more
Locations
  • Sobi Investigational Site Plovdiv, Bulgaria
  • Sobi Investigational Site Sofia, Bulgaria
  • Sobi Investigational Site Brest, France
  • Sobi Investigational Site Bron, France
View all 21 locations
View Trial Details
Recruiting

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

NCT06684314

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Investigational Site Number : 1580008 Changhua, Taiwan
  • Investigational Site Number : 1580009 Kaohsiung City, Taiwan
  • Investigational Site Number : 1580010 Kaohsiung City, Taiwan
  • Investigational Site Number : 1580005 Taichung, Taiwan
View Trial Details
Enrolling by Invitation

A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

NCT05768386

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • Orthopedic Institute for Children, Orthopedic Hemophilia Treatment Center Los Angeles, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
  • University of California San Diego, Hemophilia & Thrombosis Treatment Center San Diego, California, United States
  • University of California San Francisco - Moffit Hospital, Outpatient Hematology Clinic San Francisco, California, United States
View all 41 locations
View Trial Details
Completed

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

NCT04684940

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Hemocentro Da UNICAMP Campinas, Brazil
  • Chaim Sheba Medical Center Ramat Gan, Israel
  • Kyung Hee University Hospital at Gangdong Seoul, South Korea
View Trial Details
Completed

A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa

NCT05817812

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Investigational Site Vienna, Austria
  • Investigational Site Zagreb, Croatia
  • Investigational Site Brno, Czechia
  • Investigational Site Prague, Czechia
View all 30 locations
View Trial Details
Completed

Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

NCT06579144

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Sofia, Bulgaria
  • Sobi Investigational Site Bonn, Germany
  • Sobi Investigational site Frankfurt, Germany
  • Sobi Investigational Site Milan, Italy
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

NCT04323098

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • University of California Davis Health Sacramento, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • The Royal Adelaide Hospital Adelaide, Australia
View Trial Details
Completed

An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

NCT03901755

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Swedish Orphan Biovitrum Research Site Brno, Czechia
  • Swedish Orphan Biovitrum Research Site Prague, Czechia
  • Swedish Orphan Biovitrum Research Site (Haemophilia Center Aghia Sophia Children's Hospital) Athens, Greece
  • Swedish Orphan Biovitrum Research Site (Laikο General Hospital of Athens) Athens, Greece
View all 29 locations
View Trial Details
Completed

Gene Therapy Study in Severe Haemophilia A Patients (270-201)

NCT02576795

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +10 more
Locations
  • Queen Elizabeth Hospital Birmingham Birmingham, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • St. Thomas' Hospital London, United Kingdom
  • The Royal London Hospital London, United Kingdom
View Trial Details

Related conditions